Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab BLOOD Byrd, J. C., Hillmen, P., O'Brien, S., Barrientos, J. C., Reddy, N. M., Coutre, S., Tam, C. S., Mulligan, S. P., Jaeger, U., Barr, P. M., Furman, R. R., Kipps, T. J., Thornton, P., Moreno, C., Montillo, M., Pagel, J. M., Burger, J. A., Woyach, J. A., Dai, S., Vezan, R., James, D. F., Brown, J. R. 2019; 133 (19): 2031–42

View details for DOI 10.1182/blood-2018-08-870238

View details for Web of Science ID 000467385500009